TUBB4A

TUBB4A encodes a divergent β-tubulin isotype that incorporates into microtubules and is expressed across many tissues, originally distinguished from the neuronal-specific β4 isotype yet uniquely paired with it at the sequence level (PMID:3025656). Distinct missense mutations cause neurological disease through mechanistically separable effects on neurons and oligodendrocytes: hypomyelination-associated mutations (p.Val255Ile, p.Arg282Pro) and the combined-phenotype mutation (p.Asn414Lys) act through a dominant toxic gain-of-function that disrupts microtubule dynamics and oligodendrocyte morphology, whereas the DYT4 dystonia mutation (p.Arg2Gly) alters neuronal morphology without changing tubulin quantity, polymerization, or microtubule dynamics and is accompanied by reduced mutant mRNA consistent with haploinsufficiency (PMID:28973395, PMID:23595291). The H-ABC mutation p.Asp249Asn sits at the intradimer α/β-tubulin interface and produces overlapping, independent defects in both neurons and oligodendrocytes via altered microtubule dynamics, recapitulated in a knock-in mouse with myelination deficits and neuronal loss (PMID:23582646, PMID:32463361). A unifying cellular pathology is progressive microtubule accumulation within oligodendrocyte cell bodies and processes leading to demyelination, demonstrated in the taiep rat (p.Ala302Thr) and confirmed in human p.Asn414Lys tissue (PMID:28393430). Beyond the nervous system, TUBB4A physically interacts with MYH9 to protect the nucleus from DNA damage during constricted migration and, by promoting MYH9-mediated GSK3β ubiquitination, sustains β-catenin/NF-κB signaling and epithelial-mesenchymal transition (PMID:35589707), and it interacts with GLUT1 to support glioblastoma stem cell self-renewal (PMID:31491891).

1. 1986 High

   Established TUBB4A as a distinct, broadly expressed β-tubulin isotype, defining the molecular identity and expression pattern before any disease role was known.

   Evidence Gene sequencing, Northern blot, and tissue expression profiling of the chicken β5 ortholog

   PMID:3025656

   Open questions at the time

   • Functional consequence of isotype divergence on microtubule properties not tested
   • Human ortholog expression and neuronal relevance addressed only later
2. 2013 Medium

   Linked TUBB4A mutations to two clinically distinct disorders, raising the question of how different mutations in one tubulin produce divergent phenotypes.

   Evidence Exome/genome sequencing of families identifying de novo p.Asp249Asn (H-ABC) and p.Arg2Gly (DYT4), with structural modeling and patient-cell mRNA quantification

   PMID:23582646 PMID:23595291

   Open questions at the time

   • H-ABC mechanism inferred from structural position, not tested biochemically
   • Haploinsufficiency for DYT4 inferred from mRNA reduction, not from protein-level or functional rescue
3. 2014 Low

   Proposed that different H-ABC mutations impair tubulin function by distinct structural routes, framing mutation-specific mechanisms.

   Evidence 3D structural modeling of mutations onto the αβ-tubulin heterodimer

   PMID:24850488

   Open questions at the time

   • Computational modeling only with no biochemical validation of predicted motor/MAP interaction defects
   • Predictions not tested in cells
4. 2017 High

   Resolved the mechanistic divergence by showing mutations partition into neuronal, oligodendrocytic, or combined defects acting through gain-of-function versus distinct mechanisms.

   Evidence Cell morphology, microtubule polymerization/dynamics assays, and myelin gene expression across multiple mutations in neurons and oligodendrocytes; plus genetic mapping of the taiep rat with electron microscopy and human tissue confirmation

   PMID:28393430 PMID:28973395

   Open questions at the time

   • Molecular trigger converting microtubule accumulation into demyelination not defined
   • Why p.Arg2Gly spares microtubule dynamics yet alters neuronal morphology unresolved
5. 2020 High

   Demonstrated in vivo that a single H-ABC mutation independently damages oligodendrocytes and neurons via altered microtubule dynamics, confirming a cell-autonomous dual mechanism.

   Evidence Tubb4a p.Asp249Asn knock-in mouse with behavioral, histological, cellular, and microtubule-dynamics readouts

   PMID:32463361

   Open questions at the time

   • Dominant-toxic versus loss-of-function contribution not fully dissected
   • Therapeutic reversibility not addressed
6. 2022 High

   Identified a non-neural TUBB4A function as a MYH9 binding partner that protects the nucleus and shapes GSK3β/β-catenin/NF-κB signaling, extending its role beyond microtubule structure.

   Evidence Reciprocal Co-IP, CRISPR knockout, γH2AX/53BP1 DNA damage markers, constricted migration assays, and prostate-specific conditional knockout mouse

   PMID:35589707

   Open questions at the time

   • Relationship between this interaction and TUBB4A's tubulin function unclear
   • Relevance to neural cell types not tested
7. 2019 Medium

   Reported a TUBB4A-GLUT1 interaction supporting glioblastoma stem cell self-renewal, implicating TUBB4A in tumor metabolism/proliferation.

   Evidence Mass spectrometry on GBM tissue, proximity ligation assay, Co-IP, inhibitor treatment, and siRNA knockdown

   PMID:31491891

   Open questions at the time

   • Functional link between the interaction and downstream effects partially inferred
   • Single lab study without independent confirmation

• How the divergent mechanisms (microtubule accumulation, dynamics disruption, haploinsufficiency, and protein-interaction signaling roles) integrate into tissue-specific pathology remains unresolved.
• No unified model linking microtubule accumulation to demyelination at the molecular level
• Whether MYH9/GLUT1 interactions operate in neural cells is untested
• Structural basis of isotype-specific functions not experimentally determined